Cargando…

Inhibition of microRNA-155 ameliorates cardiac fibrosis in the process of angiotensin II-induced cardiac remodeling

Cardiac fibrosis triggered by pressure overload represents one of the major challenges in the treatment of cardiovascular diseases. MicroRNA (miRNA/miR)-155, a member of the small RNA family, has previously been demonstrated to be associated with cardiac inflammation. However, the effect of miR-155...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yuzhen, Yan, Xiaofei, Yan, Lianhua, Hu, Fen, Ma, Wenhan, Wang, Ya, Lu, Shuai, Zeng, Qiutang, Wang, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865857/ https://www.ncbi.nlm.nih.gov/pubmed/28944921 http://dx.doi.org/10.3892/mmr.2017.7584

Ejemplares similares

Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019)

The Associations Between the Polymorphisms of Vitamin D Receptor and Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Lu, Shuai, et al.
Publicado: (2016)

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2021)

The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
por: Adamcova, Michaela, et al.
Publicado: (2021)

Corrigendum: Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2022)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)

Improving vagal activity ameliorates cardiac fibrosis induced by angiotensin II: in vivo and in vitro
por: Liu, Jin-Jun, et al.
Publicado: (2015)

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016)

Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice
por: Lu, Weiwei, et al.
Publicado: (2021)

Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis
por: Varzideh, Fahimeh, et al.
Publicado: (2022)

Deficiency of MicroRNA miR‐1954 Promotes Cardiac Remodeling and Fibrosis
por: Chiasson, Valorie, et al.
Publicado: (2019)

Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro
por: He, Jian, et al.
Publicado: (2023)

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling
por: Meagher, Patrick B., et al.
Publicado: (2021)

MicroRNA‐503 promotes angiotensin II‐induced cardiac fibrosis by targeting Apelin‐13
por: Zhou, Yuhong, et al.
Publicado: (2016)

Cardiac expression of microRNA-7 is associated with adverse cardiac remodeling
por: Gupta, Manveen K., et al.
Publicado: (2021)

LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Improves Cardiac Hypertrophy and Fibrosis and Cardiac Lymphatic Remodeling in Transverse Aortic Constriction Model Mice
por: Ge, Qing, et al.
Publicado: (2020)

The MicroRNA miR-155 Is Essential in Fibrosis
por: Eissa, Mousa G., et al.
Publicado: (2019)

Hydrogen gas inhalation ameliorates cardiac remodelling and fibrosis by regulating NLRP3 inflammasome in myocardial infarction rats
por: Nie, Chaoqun, et al.
Publicado: (2021)

Relaxin Family Member Insulin‐Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models
por: Maruyama, Sonomi, et al.
Publicado: (2018)

Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis
por: Wang, Yiwen, et al.
Publicado: (2019)

MicroRNA as a Therapeutic Target in Cardiac Remodeling
por: Chen, Chao, et al.
Publicado: (2017)

MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2
por: Zhou, Yu, et al.
Publicado: (2017)

Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression
por: Niu, Lian-Jie, et al.
Publicado: (2021)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction
por: Tony, Hasahya, et al.
Publicado: (2015)

Prolylcarboxypeptidase Alleviates Hypertensive Cardiac Remodeling by Regulating Myocardial Tissue Angiotensin II
por: Nguyen, Binh Y., et al.
Publicado: (2023)

Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
por: Liu, Xiao, et al.
Publicado: (2019)

Intradialytic hypotension and cardiac remodeling: should we consider the renin-angiotensin-aldosterone system?
por: Wang, Juanli, et al.
Publicado: (2021)

Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming
por: Bektik, Emre, et al.
Publicado: (2019)

Hydrogen Sulfide Ameliorates Homocysteine-Induced Cardiac Remodeling and Dysfunction
por: Kar, Sumit, et al.
Publicado: (2019)

Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
por: Zhao, Jianquan, et al.
Publicado: (2018)

Cut the YAP: Limiting Fibrosis in Pathologic Cardiac Remodeling
por: Small, Eric M., et al.
Publicado: (2020)

Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
por: Sato, Teruki, et al.
Publicado: (2019)

Overexpression of peptidase inhibitor 16 attenuates angiotensin II–induced cardiac fibrosis via regulating HDAC1 of cardiac fibroblasts
por: Deng, Mengqing, et al.
Publicado: (2020)

Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis
por: Wang, Juan, et al.
Publicado: (2016)

Sacubitril Ameliorates Cardiac Fibrosis Through Inhibiting TRPM7 Channel
por: Jia, Tian, et al.
Publicado: (2021)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Targeted inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis and Preserves Heart Function in Adverse Cardiac Remodeling
por: Zhang, Jie, et al.
Publicado: (2017)

Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation
por: Lin, Shuang, et al.
Publicado: (2022)

BAF155 promotes cardiac hypertrophy and fibrosis through inhibition of WWP2-mediated PARP1 ubiquitination
por: Zhang, Naijin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m8anndhbj112r0eeee3utb2lv7